Cargando…
SARS-CoV-2 variants in immunocompromised COVID-19 patients: The underlying causes and the way forward
Autores principales: | Bansal, N., Raturi, M., Bansal, Y. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Société française de transfusion sanguine (SFTS). Published by Elsevier Masson SAS.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8714679/ https://www.ncbi.nlm.nih.gov/pubmed/34973463 http://dx.doi.org/10.1016/j.tracli.2021.12.006 |
Ejemplares similares
-
Locally harvested Covid-19 convalescent plasma could probably help combat the geographically determined SARS-CoV-2 viral variants
por: Raturi, Manish, et al.
Publicado: (2021) -
Seroprevalence of SARS-CoV-2 among blood donors: A practical serosurveillance tool for COVID-19
por: Bansal, N., et al.
Publicado: (2022) -
SARS-CoV-2 intra-host evolution during prolonged infection in an immunocompromised patient
por: Quaranta, Erika Giorgia, et al.
Publicado: (2022) -
SARS-CoV-2 variants and pregnant Women: A cause for Concern?
por: Onyinyechi Chionuma, Joy, et al.
Publicado: (2022) -
Covid-19 convalescent plasma therapy: Analyzing the factors that led to its failure in India
por: Bansal, Naveen, et al.
Publicado: (2021)